60 Degrees Pharmaceuticals Warrant
SXTPW
8 hedge funds and large institutions have $17.3K invested in 60 Degrees Pharmaceuticals Warrant in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
60% more funds holding
Funds holding: 5 → 8 (+3)
29% less capital invested
Capital invested by funds: $24.3K → $17.3K (-$6.98K)
29.61% less ownership
Funds ownership: 29.61% → 0% (-30%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.19K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$932 |
| 3 |
VF
Virtu Financial
New York
|
+$687 |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$215 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$47 |
| 2 |
CS
Clear Street
New York
|
-$14 |
SXTPW Hedge Fund Activity: Q3 2025 in Review
8 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals Warrant (SXTPW) for Q3 2025, worth a combined $17.3K — down 29% from $24.3K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new SXTPW positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.19K. The largest seller was UBS Group, cutting an estimated $47.
- 8 institutional investors held 60 Degrees Pharmaceuticals Warrant (SXTPW) as of Q3 2025, up from 5 in Q2 2025.
- Funds reported $17.3K of 60 Degrees Pharmaceuticals Warrant stock for Q3 2025, down 29% quarter-over-quarter.
- 3 funds opened new 60 Degrees Pharmaceuticals Warrant positions in Q3 2025 and 0 closed out, a net change of +3 holders.
- The largest 60 Degrees Pharmaceuticals Warrant buyer in Q3 2025 was Susquehanna International Group, an estimated $1.19K added.
- The largest 60 Degrees Pharmaceuticals Warrant seller in Q3 2025 was UBS Group, an estimated $47 sold.
Based on aggregated 13F filings for Q3 2025.